Where does Valerion Therapeutics, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Valerion Therapeutics, LLC ranks #25,485 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Valerion Therapeutics, LLC hold?

Valerion Therapeutics, LLC holds 11 US utility patents granted between 2015 and 2020, spanning 7 technology areas.

What is Valerion Therapeutics, LLC's Innovation Score?

Valerion Therapeutics, LLC has an Innovation Score of 32.9 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Valerion Therapeutics, LLC focus on?

Valerion Therapeutics, LLC's top technology area is C07K (Peptides) with 11 patents, ranking #825 of 3,615 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Valerion Therapeutics, LLC's patent grant rate increasing or decreasing?

Valerion Therapeutics, LLC's recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Valerion Therapeutics, LLC's patents?

Valerion Therapeutics, LLC's patents average 29.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Valerion Therapeutics, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Valerion Therapeutics, LLC

USPTO PatentsView assignee record - 11 granted patents across 7 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Valerion ranks #25,485 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 7 technology areas.

#25,485
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (32.9/100): 29.6
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R25485 · US Corporation #25,485 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 11 grants
MID-PACK #25,485/49,997
PHOTO-FINISH Vacuum
CPC-NARROW C07K · 7 areas
INNOV-THIN 32.9/100
CLAIMS-DENSE 29.6 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Vacuum Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Valerion’s 32.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (26%) Velocity 0.0 pts (0%) Breadth 9.4 pts (28%) Claim depth 15.0 pts (45%)

Qualcomm Incorporated · highest

85
Valerion Therapeutics · this assignee

33
3D Lighting… · lowest

7

What this shows Valerion's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Valerion?

Each dot is one of Valerion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Valerion’s own 29.6 claims/patent is ABOVE the 16.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Valerion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Valerion's grants concentrate

Valerion Therapeutics, LLC is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2015. By volume, Valerion sits between VYGON and Ventus Therapeutics U.S., Inc..

Vygon

11
Vacuum

11
Valencia Bioscien…

11
Valeo Lighting Hu…

11
Vanguard Group

11
Vascular Access

11
Vascular Graft So…

11
Ventus Therapeuti…

11
Valerion Therapeu… ◀

11

What this shows Valerion holds 11 patents at rank #25,490, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Valerion

By rank, the assignees closest to #25,490 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Valerion's primary technology class.

Valerion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Valerion Therapeutics, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	9.1%
2016	1	9.1%
2017	1	9.1%
2018	1	9.1%
2019	4	36.4%
2020	3	27.3%

Which technologies does Valerion Therapeutics, LLC patent most?

C07K - Peptides 11

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 7

C12Y - Enzymes 6

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Valerion Therapeutics, LLC's patent record in context - here's where to go next.

Valerion Therapeutics, LLC's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #25,485 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Valerion Therapeutics, LLC against VYGON, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.